GlassScriptPhysician profile
Katie L Frederickson
NPI 1104237544
$1,777.96
in general payments reported to CMS, 2019-2025
16 companies · $254 in 2025
The $254 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $570 · 2022: $549 · 2023: $294 · 2024: $111 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $658.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $422.05 | 2021-2022 | |
| Genzyme Corporation | $263.32 | 2022-2025 | |
| Abbvie INC. | $246.20 | 2021-2023 | |
| Alkermes, INC. | $227.76 | 2023-2024 | Aristada, Lybalvi, Aristada Initio |
| Janssen Scientific Affairs, LLC | $142.27 | 2025 | Tremfya |
| Incyte Corporation | $140.88 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $122.97 | 2021-2023 | Dupixent |
| Mayne Pharma Commercial LLC | $40.93 | 2021 | |
| Novartis Pharmaceuticals Corporation | $31.80 | 2022 | |
| Sanofi-Aventis U.S. LLC | $24.33 | 2021 | |
| Pfizer INC. | $21.73 | 2021 | |
| Leo Pharma INC. | $21.69 | 2021 | |
| Sun Pharmaceutical Industries INC. | $20.78 | 2021 | |
| Almirall LLC | $20.44 | 2021 | |
| Vyne Pharmaceuticals INC. | $18.39 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Epi Health, LLC | $12.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Frederickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.